(1)
Yamashita, Y.; Hori, Y.; Kosako, H.; Oiwa, T.; Warigaya, K.; Mushino, T.; Murata, S.; Fujimoto, M.; Nishikawa, A.; Murata, S.- ichi; Sonoki, T.; Tamura, S. Brentuximab Vedotin for Refractory Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma in Leukemic Phase With <em>RUNX3</em&gt; Overexpression. Hematol Rep 2020, 12.